Search tool

Displaying 81 - 90 of 994

Picture ambulance

New EMCDDA report sheds light on drug-related hospital emergencies

Data from hospital emergency departments show that every year in Europe thousands of individuals experience drug-related poisoning and other harms, requiring some kind of medical assistance.

Publication thumbnail

Hepatitis C among drug users in Europe: epidemiology, treatment and prevention

Hepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely contribution to raising awareness of the hepatitis C epidemic in Europe and the opportunities now opening up to...

Close-up of virus

New EMCDDA report shows grounds for hope in treating hepatitis C

Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus. In a new report published today on World Hepatitis Day, the EU drugs agency (EMCDDA) looks...

Risk assessment α-PVP thumbnail

Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP)

This publication presents the data and findings of the risk assessment on α-PVP (1-phenyl- 2-(1-pyrrolidinyl)-1-pentanone), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2015. α-PVP is the...

Libe Committée visit 2016

European Parliament LIBE Committee members pay fact-finding visit to the EMCDDA

Members of the European Parliament Committee on Civil Liberties, Justice and Home Affairs (LIBE) start a two-day visit to the EMCDDA today where they will hear presentations on the agency’s contribution to...

Publication's cover

EMCDDA–Europol 2015 Annual Report on the implementation of Council Decision 2005/387/JHA

This report presents the key activities performed by the EMCDDA and Europol in 2015 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control...

EMCDDA Director at German Bundestag hearing on new psychoactive substances

EMCDDA Director Alexis Goosdeel is in Berlin today where he is speaking at a public hearing at the German Parliament (Bundestag) on the issue of new psychoactive substances (NPS). The hearing is...

mdmb-chimica cover

EMCDDA–Europol Joint Report on MDMB-CHMICA

In February 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate, commonly known as MDMB-CHMICA, through a joint assessment. The two organisations concluded that sufficient...

publication thumbnail

Annual accounts 2015

These are the EMCDDA's final annual accounts for the financial year 2015.

ENP group photo

EMCDDA conference takes stock of project with ENP partner countries

The EU drugs agency (EMCDDA) is hosting a conference in Lisbon today marking the end of a 30-month technical cooperation project within the framework of the European Neighbourhood Policy (ENP).